Le Lézard
Classified in: Health, Business
Subjects: CON, JVN, TRI

Adventist Health System Leverages Investment in Agfa HealthCare Technology to Improve Care Quality


MORTSEL, Belgium and GREENVILLE, South Carolina, Feb. 8, 2018 /PRNewswire/ --

Florida Hospital, part of  Adventist Health System, is turning to Agfa HealthCare to make an investment in Direct Radiography (DR). Implementing 80 DR Upgrades at 18 sites allows Florida Hospital to advance its value-based care initiative by delivering the benefits of DR. This upgrade allows the hospital to optimize the experience and care of patients, provide a smooth, efficient workflow for clinicians, and enhance the hospital's productivity by making the processes more efficient.

"Our goal is to increase productivity  while continuing working toward our mission to provide exceptional, whole-person care," said Elizabeth Evans, modality manager at Florida Hospital Imaging Enterprise. "As a national leader in quality, safety and patient satisfaction, it is important for us to invest in technology, as innovation will allow us to offer the best care to our patients."

For more information visit: http://global.Agfahealthcare.com/us/digital-radiography/

For an image, courtesy of Agfa HealthCare, click here

About Agfa HealthCare
Agfa HealthCare is a leading provider of diagnostic imaging and healthcare IT solutions for hospitals and care centers around the world. The business group is a major player on the diagnostic imaging market, providing analog and digital technology, as well as IT solutions to meet the needs of specialized clinicians.

The business group is also a key provider on the healthcare information solutions market, integrating the administrative, financial and clinical workflows of individual hospitals and hospital groups.

Agfa,  the Agfa rhombus, and MUSICA are trademarks of AGFA-Gevaert N.V. Belgium or its affiliates. All rights reserved.

All information contained herein is intended for guidance purposes only, and characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible, but shall not be responsible for any typographical error.

Only the English version of this press release is legally valid.  The versions in other languages only represent a translation of the original English version.

Contact:
Miriam Ladin
Director, Marketing Communications, Americas
+1-978-284-7777
[email protected]

SOURCE Agfa HealthCare


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: